Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Lineage Cell Therapeutics Inc is a biotechnology company focused on developing innovative cell-based therapies for the treatment of a range of diseases, particularly those affecting the eye and nervous system

The company is dedicated to utilizing its proprietary technology and expertise in cell therapy to create regenerative medicine solutions that can improve patient outcomes. By leveraging advancements in stem cell research and regenerative medicine, Lineage aims to address unmet medical needs through its clinical programs and preclinical research initiatives, contributing to the evolution of therapeutic strategies in regenerative healthcare.